Eli Lilly Investor-State Suit
The Canadian government responded to a $500 million suit filed by Eli Lilly & Co. with a blistering attack on the intellectual property practices of the pharmaceutical company.
Accusing Lilly of adopting a “scattershot approach” to applying for patents, Canada’s government presented a detailed rebuttal to claims Lilly made in an investor-state lawsuit. Lilly, it said, tended to file dozens of patent applications for its drugs, claiming new uses for compounds on the basis of little evidence, only to abandon the majority of those applications.
